Downloads

Development of Anticancer Agents: Wizardry with Osmium


Download Type: Adobe PDF

The drawbacks of currently used cancer chemotherapeutics have led to the development of novel anticancer agents with alternative modes of action. Compounds featuring an osmium center are a promising class of new therapeutics with widely tunable activity.

Platinum compounds are one of the pillars of modern cancer chemotherapy. The apparent disadvantages of existing chemotherapeutics have led to the development of novel anticancer agents with alternative modes of action. Many complexes of the heavy metal osmium (Os) are potent growth inhibitors of human cancer cells and are active in vivo, often superior or comparable to cisplatin, as the

benchmark metal-based anticancer agent, or clinically tested ruthenium (Ru) drug candidates. Depending on the choice of ligand system, osmium compounds exhibit diverse modes of action, including redox activation, DNA targeting or inhibition of protein kinases. In this review, we highlight recent advances in the development of osmium anticancer drug candidates and discuss their cellular mechanisms of action.

Share this download

More services